ArticleMolecular diversity2025

Combination of ligand‑based and structure‑based virtual screening for the discovery of novel Janus kinase 2 inhibitors against philadelphia-negative myeloproliferative neoplasms.

Binyou Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.